オプションチェーンは、Autolus Therapeuticsの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Autolus Therapeuticsの市場センチメントを評価します。.

Autolus Therapeutics (NASDAQ:AUTL) 株価情報, オプションチェーン

Autolus Therapeutics

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Autolus Therapeutics plc - American Depositary Shares

Autolus Therapeutics PLC

Austal Ltd

<a href="https://x.com/Banana3Stocks/status/1857524296341745855" title="https://x.com/Banana3Stocks/status/1857524296341745855">https://x.com/Banana3Stocks/status/1857524296341745855</a>

Trading Ideas

IRBT

Shares Of iRobot See Volume, Popular Account On X Announces They Bought The Stock

WIIM

23andMe shares are trading lower. The stock may be moving on continued weakness after reporting a Q2 revenue miss yesterday.

PepsiCo's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NYSE">PEP</a>) short percent of float has risen 7.09% since its last report. The company recently reported that it has 18.59 million shares sold short, which is 1.36% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.94 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>PepsiCo Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731703522_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for PepsiCo has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing PepsiCo's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, PepsiCo's peer group average for short interest as a percentage of float is 8.19%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Peering Into PepsiCo's Recent Short Interest

Global E Online's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLBE#NYSE">GLBE</a>) short percent of float has fallen 9.51% since its last report. The company recently reported that it has 7.98 million shares sold short, which is 8.28% of all regular shares that are available for trading. Based on its trading volume, it would take traders 11.57 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Global E Online Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731703517_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Global E Online has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Global E Online's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Global E Online's peer group average for short interest as a percentage of float is 9.58%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

GLBE

Peering Into Global E Online's Recent Short Interest

Packaging Corp of America's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PKG#NYSE">PKG</a>) short percent of float has fallen 18.83% since its last report. The company recently reported that it has 1.23 million shares sold short, which is 1.81% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.87 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Packaging Corp of America Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731703511_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Packaging Corp of America has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Packaging Corp of America's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Packaging Corp of America's peer group average for short interest as a percentage of float is 5.12%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(PKG) - Analyzing Packaging Corp of America's Short Interest

CABA

Cabaletta Bio shares are trading lower after Wells Fargo cut its price target on the stock from $20 to $12.

McDonald&#8217;s Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) shares are trading lower Friday on reports indicating the company will spend $100 million plan to address the impact of a recent E. Coli outbreak. 
What To Know: The outbreak, linked to slivered onions used in Quarter Pounder burgers, affected 104 individuals across 14 states and resulted in one death. In response, McDonald's temporarily removed Quarter Pounders from menus at 20% of its U.S. locations. The outbreak was confirmed by the U.S. Centers for Disease Control and Prevention (CDC) in October, prompting swift action from the company.
To address the crisis, McDonald's <a href="https://www.qsrmagazine.com/story/mcdonalds-to-spend-100-plus-million-to-aid-operators-impacted-by-e-coli-outbreak/">will invest</a> $35 million in marketing and advertising campaigns to rebuild customer trust and foot traffic. Additionally, $65 million will be directed toward franchisee support, including deferrals on rent and royalties.
The outbreak hit as the company was working to improve sales through discounts and promotions, erasing nearly all of McDonald&#8217;s year-to-date gains. A $5 value meal had gained traction with low-income customers, boosting guest counts in the third quarter before the E. Coli crisis disrupted the momentum. Weekly sales dropped nearly 12% in late October and remain below last year's levels despite modest recovery in recent weeks.
MCD Price Action: McDonald shares were down 2.01% at $292.56 at the time of writing, according to<a href="https://pro.benzinga.com/dashboard"> Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://benzinga.slack.com/archives/D072651PB4K/p1727794380964569"><img loading="lazy" decoding="async" width="1024" height="542" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/15150910/MCD-1024x542.png" alt="" class="wp-image-651176" style="width:476px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/15150910/MCD-1024x542.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/15150910/MCD-300x159.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/15150910/MCD-768x406.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/15150910/MCD.png 1170w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/health-care/24/11/42017583/trumps-go-wild-on-health-plan-puts-rfk-jr-in-charge-what-it-means-for-cannabis-and-psychedelics-reform">Trump&#8217;s &#8216;Go Wild On Health&#8217; Plan Puts RFK Jr. In Charge: What It Means For Cannabis And Psychedelics Reform</a></li>
</ul>
Image via Shutterstock.

News

Movers

McDonald Shares Are Down Today: What's Going On?

BOXL

Boxlight Corp shares are trading lower. Alliance Global Partners downgraded the stock from Buy to Neutral on Thursday.

GNLX

Genelux shares are trading lower. HC Wainwright & Co. cut its price target on the stock from $32 to $30.

Benzinga readers see more gains for Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) after the leading cryptocurrency passed multiple <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41778425/bitcoins-all-time-high-a-groundbreaking-milestone-and-strong-post-election-rally-coming-ex">new all-time highs</a> after <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41770352/bitcoins-future-under-president-elect-donald-trump-a-look-at-his-crypto-policies">Donald Trump's re-election</a>. 
The current all-time high for Bitcoin is $93,434.36, which was reached on Nov. 13. Before that, Bitcoin knocked out various prices in the $80,000s.
Benzinga recently asked its readers: "Which cryptocurrency do you think will see the biggest price increase by the end of 2025?" 
The results were:
<ul>
<li>Bitcoin: 40%</li>
<li>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>): 36%</li>
<li>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>): 11%</li>
<li>Pepe Coin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">PEPE</a>): 8%</li>
<li>Shiba Inu Coin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>): 7%</li>
</ul>
The poll found Bitcoin to be the winner, which comes with the cryptocurrency already up significantly over the last year and trading near all-time highs.
Dogecoin finished in second place getting 36% of the vote. While Dogecoin is up significantly over the past week and year, the coin still trades below its all-time highs.
Read Also: <a href="https://www.benzinga.com/general/education/24/11/41882342/heres-how-much-100-in-dogecoin-today-could-be-worth-if-doge-hits-new-all-time-highs-2">Here&#8217;s How Much $100 In Dogecoin Today Could Be Worth If DOGE Hits New All-Time Highs</a>
Bitcoin winning the poll shouldn't come as a huge surprise. Another recent <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41951961/bitcoin-to-100k-benzinga-readers-predict-if-btc-can-hit-new-milestone-before-end-of-2024">Benzinga poll</a> saw 73% of readers say they believed Bitcoin would hit $100,000 before the end of 2024, adding to the year-to-date gains.
Here are the current prices, seven-day returns, year-to-date returns and all-time highs for the cryptocurrencies in the poll.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td></td>
<td>Price (11/15/24)</td>
<td>7-Day Return</td>
<td>Year-to-Date Return</td>
<td>All-Time High Price and Date</td>
</tr>
<tr>
<td>Bitcoin</td>
<td>$90,570.10</td>
<td>+17.4% </td>
<td>+105.2% </td>
<td>$93,434.36, 11/13/24</td>
</tr>
<tr>
<td>Dogecoin</td>
<td>$0.3720</td>
<td>+88.9%</td>
<td>+304.3%</td>
<td>$0.7376, 05/08/21</td>
</tr>
<tr>
<td>Ethereum</td>
<td>$3,052.10</td>
<td>+2.8%</td>
<td>+29.9%</td>
<td>$4,891.70, 11/16/21</td>
</tr>
<tr>
<td>Pepe </td>
<td>$0.0000221</td>
<td>+106.1%</td>
<td>+1,481.9%</td>
<td>$0.00002524, 11/13/24</td>
</tr>
<tr>
<td>Shiba Inu</td>
<td>$0.00002429</td>
<td>+28.7%</td>
<td>+127.6%</td>
<td>$0.00002517, 10/27/21</td>
</tr>
</tbody>
</table>
</figure>
The chart shows that Bitcoin and Pepe have hit all-time highs in recent days. Dogecoin, Ethereum and Shiba Inu all still trade below their all-time high levels, which were reached in 2021 during a year to remember for the cryptocurrency sector.
Time will tell if Benzinga readers are right in predicting Bitcoin as the likely top gainer by the end of 2025 of the five cryptocurrencies.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/education/24/11/41946785/if-you-invested-100-in-pepe-coin-at-launch-heres-how-much-youd-have-today">If You Invested $100 In Pepe Coin At Launch, Here&#8217;s How Much You&#8217;d Have Today</a></li>
</ul>
The study was conducted by Benzinga from Nov. 14 through Nov. 15, 2024, and included the responses of a diverse population of adults 18 or older. Opting into the survey was completely voluntary, with no incentives offered to potential respondents. The study reflects results from 124 adults.
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Exclusives

$BTC

$DOGE

$ETH

$PEPE

$SHIB

Bitcoin, Ethereum, Dogecoin, Pepe, Shiba Inu: Which Cryptocurrency Do Benzinga Readers Think Will Gain The Most By End Of 2025?

Bitcoin Depot shares are trading lower. The stock may be moving on continued weakness following worse-than-expected Q3 sales results reported on Wednesday.

BTOC

Armlogi shares are trading lower after the company reported a year-over-year decrease in Q1 EPS results.

Shares Of U.S. Steel See Volume; Bloomberg Report Titled, "Trump Pivots to Silence on US Steel Deal Amid Growing Tensions Trump had pledged to block Nippon Steel's $14.1 billion bid"

ZNTL

Zentalis Pharmaceuticals shares are trading lower after Guggenheim cut its price target on the stock from $12 to $8.

A few decades ago, you'd made it if you hit that magic million-dollar mark. You were rich. These days, though, with skyrocketing costs and social media awash with luxury-laden highlights, it can feel like everyone's got a cool million in their back pocket. The truth? That's more illusion than reality. As <a href="https://www.benzinga.com/personal-finance/24/03/37520117/dave-ramsey-reveals-people-arent-as-well-off-as-you-think-8-out-of-10-people-probably-cant-affor">financial guru Dave Ramsey put it</a>: "8 out of 10 people probably can't afford the home they're living in and the car they're driving."
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
<li>Many are using this retirement income calculator to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on how on what&#8217;s behind this formula.</a></li>
<li><a href="https://www.benzinga.com/money/100k-cd">$100K Sitting In A CD Account, Should I Move Money Into The Stock Market?</a></li>
</ul>
Social media tends to amplify what looks like wealth, leading to this widespread perception that everyone's swimming in money. But peek behind the scenes and it's clear that not as many people are flush with cash as it seems. So, let's break it down – how many Americans have a net worth of $1 million or more?
Spoiler Alert: It's Not As Many As You'd Think
According to the 2022 Survey of Consumer Finances by the Federal Reserve, only about 12% of U.S. households have a net worth over $1 million. This means that the vast majority – 88% – are nowhere near that level. Keep in mind that this is "household" net worth, which likely assumes a two-person income and combined assets.&nbsp;
Wealth is highly concentrated and while the average <a href="https://www.benzinga.com/personal-finance/financial-advisors/23/12/36078165/if-the-average-american-household-is-a-millionaire-with-a-net-worth-of-1-06-m">U.S. household net worth is $1.06 million</a>, the median net worth is much lower, at $192,700. Translation: A few very wealthy households are driving up the average but most people are much closer to that median number.
Trending: ‘Beating the market through ethical real estate investing' —<a href="https://www.benzinga.com/money/invest-with-roots"> this platform aims to give tenants equity in the homes they live in while scoring 17.38% average annual returns for investors – here&#8217;s how to join with just $100</a>
Where Are the Millionaires?
Certain states and age groups stand out for context. New Jersey, for instance, has the highest rate of millionaire households – about 9.76% of homes there have a net worth over $1 million. Age-wise, those between 65 and 74 have the highest average net worth at $1.2 million but the median for that same group is just $266,400. In other words, while some retirees have saved a bundle, many are just getting by.
<a href="https://www.benzinga.com/personal-finance/24/09/41075540/is-your-401-k-balance-above-average-find-out-if-youre-beating-most-savers">401(k) balances tell a similar story</a>. The average 401(k) balance for Americans aged 65 and older is $272,588 but the median is just $88,488 – meaning half of people have less than that amount saved.
What Does It Mean to Have $1 Million?
A net worth of $1 million isn't the same as having that amount sitting in the bank. Net worth includes assets like home equity, investments and retirement accounts – things that aren't easily converted to cash. And with inflation driving up living costs, many Americans now consider $2.2 million the new minimum to feel "wealthy."
See Also: Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.
Are We All Millionaires Yet?
The short answer is no, not even close. And while social media may make it seem like everyone else is living in luxury, the reality is far more modest. In fact, most people are still trying to build their financial safety nets, making those few million-dollar net worthy seem rare and impressive.
Next time you scroll through someone's highlight reel, remember: what you see is just that – a highlight.&nbsp;
If you&#8217;re looking to hit that million-dollar mark yourself, it's less about flash and more about patience and steady saving. Say you're 35 and you've got $20,000 already saved. Assuming an average annual return of 7% – a common benchmark for long-term investments – you'd need to save around $5,000 a year or about $417 a month to reach $1 million by age 65. If you increase that amount as your income grows, you'll reach your goal even sooner. The key is consistency, letting time and compounding work their magic.
Of course, this is just one scenario and everyone's situation differs. The best way to map out your path is by <a href="https://www.benzinga.com/money/can-you-guess-how-many-americans-successfully-retire-with-1-million-saved">talking to a financial advisor</a>. They can help you customize a strategy that fits your income, goals and lifestyle, whether you're aiming for that million or a secure retirement.
Read Next:
<ul>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
<li>Studies show 50% of consumers think Financial Advisors cost much more than they do —<a href="https://www.benzinga.com/money/money-pickle"> to debunk this, this company provides matching for free and a complimentary first call with the matched advisor.</a></li>
</ul>

Personal Finance

Can You Guess What Percent Of People Have $1 Million Saved? Spoiler Alert – It's Far Lower Than Most Statistics Lead You To Believe

In the current market session, AeroVironment Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVAV#NASDAQ">AVAV</a>) share price is at $205.00, after a 0.37% spike. Moreover, over the past month, the stock fell by 7.54%, but in the past year, increased by 56.33%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2024/1731702712_0.png" alt="Past Year Chart" />

<h3>A Look at AeroVironment P/E Relative to Its Competitors</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
AeroVironment has a better P/E ratio of 97.73 than the aggregate P/E ratio of 80.64 of the Aerospace &amp; Defense industry. Ideally, one might believe that AeroVironment Inc. might perform better in the future than it's industry group, but it's probable that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1731702712_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

AVAV

A Look Into AeroVironment Inc's Price Over Earnings

BIOR

Biora Therapeutics shares are trading lower. The stock may be moving on continued weakness following a Q3 earnings miss and a year-over-year decline in revenue reported on Thursday

GCTS

GCT Semiconductor Holdings shares are trading lower. The company reported Q3 financial results.

ONFO

Onfolio Holdings shares are trading higher after the company reported a year-over-year increase in Q3 financial results.

AMGN

GILD

IONS

VKTX

Shares of pharmaceutical and healthcare stocks are trading lower. The sector has been under pressure after president-elect Trump nominated Robert F. Kennedy Jr. to lead the HHS.

Mizuho Securities analyst Salim Syed has maintained their bullish stance on AUTL stock, giving a Buy rating yesterday. Salim Syed has given his Buy...

Buy Recommendation for Autolus Therapeutics Driven by Favorable Safety and Efficacy of Aucatzyl

Autolus Therapeutics (AUTL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Yanan Zhu f...

Autolus Therapeutics Receives 'Buy' Rating: Aucatzyl's FDA Approval and Strategic Launch Plan Bolster Market Position

Reports Q3 revenue $0, consensus $130,000. "With the U.S. Food and Drug Administration having approved AUCATZYL for the treatment of adult B-cell A...

Autolus Therapeutics reports Q3 EPS (31c), consensus (21c)

Autolus estimates that, with its current cash and cash equivalents, it is well capitalized to drive the full launch and commercialization of obe-ce...

Autolus estimates cash to drive full launch, commercialization of obe-cel

Jefferies analyst Kelly Shi maintained a Buy rating on Autolus Therapeutics (AUTL – Research Report) today and set a price target of $13.00. The co...

Jefferies Reaffirms Their Buy Rating on Autolus Therapeutics (AUTL)

Autolus Therapeutics ( ($AUTL) ) has provided an announcement. Autolus Therapeutics has achieved a pivotal milestone with the FDA's approval of AUC...

Autolus Therapeutics Wins FDA Approval for AUCATZYL®

Autolus Therapeutics ( ($AUTL) ) has provided an update. Autolus Therapeutics plc has achieved FDA approval for AUCATZYL&#xAE;, a treatment for relapsed...

Autolus Therapeutics Gains FDA Approval for AUCATZYL®

Autolus Therapeutics plc 2024 Q3 - Results - Earnings Call Presentation

Autolus Therapeutics plc (AUTL) Q3 2024 Earnings Call Transcript

Redburn Atlantic upgraded Autolus Therapeutics (AUTL) to Buy from Neutral with an unchanged price target of $13. One week earlier than expected, Au...

Autolus Therapeutics upgraded to Buy from Neutral at Redburn Atlantic

AUTL

Health Care

Press Releases

Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) B-Cell acute lymphoblastic leukemia (ALL) patients at the 2024 European Hematology Association (EHA) Congress

Autolus Therapeutics to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024

Earnings

Autolus Therapeutics Reports Second Quarter 2024 Financial Results and Business Updates

Autolus Therapeutics Presents Clinical Data Update at the Society of Hematologic Oncology (SOHO) Annual Meeting 2024

Management

Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer

Autolus Therapeutics Presents Clinical Data Update at the 2024 Lymphoma, Leukemia & Myeloma Congress

Autolus Therapeutics to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024

Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024 in One Oral Presentation and Three Poster Presentations

General

Autolus Therapeutics Announces FDA Approval of AUCATZYL® (obecabtagene autoleucel – obe-cel) for adults with relapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL)

Autolus Therapeutics Reports Third Quarter 2024 Financial Results and Business Updates

Comments

Autolus Therapeutics

Autolus Therapeutics (AUTL) オプション

Autolus Therapeutics (NASDAQ:AUTL) 株価情報, オプションチェーン

ニュース

パートナーシップ

ベンジンガ・グローバル